Literature DB >> 31773219

Surgery of the Primary Tumor Offers Survival Benefits of Breast Cancer with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis.

Qi-Tong Chen1, Li-Yun Zeng1, Deng-Jie Ouyang1, Piao Zhao1, Qiong-Yan Zou1, Lei Pei1, Na Luo1, Wen-Jun Yi2.   

Abstract

BACKGROUND: Controversy exists around the locoregional management of the primary tumor for breast cancer associated with synchronous ipsilateral supraclavicular lymph node metastasis (sISLM) due to the rarity of the disease and limited available data. This study aimed to compare outcomes of patients in the Surveillance, Epidemiology, and End Results (SEER) database with sISLM who underwent surgical resection and radiation of the primary tumor with those who did not.
METHODS: This population-based retrospective study included breast cancer patients with sISLM without distant metastases from 2004 to 2016 in the SEER database. In this study, patients had been stratified by operative management, and propensity score matching (PSM) had been successfully applied.
RESULTS: A total of 1172 breast cancer patients with sISLM were included in the study: 863 (73.6%) of patients underwent the primary tumor resection, and 309 (26.4%) patients did not undergo surgery. The median survival time in the surgery group was longer compared to the nonsurgery group in the overall cohort and the PSM cohort. We concluded that the primary tumor resection was associated with improved survival. Subgroup analysis further demonstrated that local surgery was not inferior to radical surgery.
CONCLUSION: For selected breast cancer patients with sISLM, surgery is a promising local intervention which may improve the survival.

Entities:  

Year:  2020        PMID: 31773219     DOI: 10.1007/s00268-019-05293-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Supraclavicular recurrence after early breast cancer: a curable condition?

Authors:  Anders N Pedersen; Susanne Møller; Karina D Steffensen; Vera Haahr; Merete Jensen; Mette M Kempel; Søren L Jepsen; Ebbe L Madsen; Anne Roslind; Erik Sandberg; Claudia Schöllkopf; Peter G Sørensen; Karen Margrethe Windfeldt; Michael Andersson
Journal:  Breast Cancer Res Treat       Date:  2010-05-08       Impact factor: 4.872

2.  Prognosis of breast cancer after supraclavicular lymph node metastasis: not a distant metastasis.

Authors:  Shin-Cheh Chen; Hsien-Kun Chang; Yung-Chang Lin; Wai-Man Leung; Chien-Sheng Tsai; Yun-Chung Cheung; Swei Hsueh; Lai-Chu See; Miin-Fu Chen
Journal:  Ann Surg Oncol       Date:  2006-09-08       Impact factor: 5.344

3.  Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.

Authors:  R A Brito; V Valero; A U Buzdar; D J Booser; F Ames; E Strom; M Ross; R L Theriault; D Frye; S W Kau; L Asmar; M McNeese; S E Singletary; G N Hortobagyi
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

4.  Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.

Authors:  Mariana Chavez-MacGregor; Elizabeth A Mittendorf; Christina A Clarke; Daphne Y Lichtensztajn; Kelly K Hunt; Sharon H Giordano
Journal:  Oncologist       Date:  2017-06-07

5.  The prognostic significance of the supraclavicular lymph node metastases in breast cancer patients.

Authors:  I C Kiricuta; J Willner; O Kölbl; W Bohndorf
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-01-15       Impact factor: 7.038

6.  Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.

Authors:  Eleanor E R Harris; Wei-Ting Hwang; Farshad Seyednejad; Lawrence J Solin
Journal:  Cancer       Date:  2003-11-15       Impact factor: 6.860

Review 7.  A meta-analysis of the prognosis in patients with breast cancer with ipsilateral supraclavicular lymph node metastasis versus patients with stage IIIb/c or IV breast cancer.

Authors:  Xu-Hong Liu; Lei Zhang; Bo Chen
Journal:  Chronic Dis Transl Med       Date:  2016-02-19

8.  Treatment Outcome of Breast Cancer with Pathologically Proven Synchronous Ipsilateral Supraclavicular Lymph Node Metastases.

Authors:  Jinhong Jung; Su Ssan Kim; Seung Do Ahn; Sang-Wook Lee; Sei-Hyun Ahn; Byung Ho Son; Jong Won Lee; Eun Kyung Choi
Journal:  J Breast Cancer       Date:  2015-06-26       Impact factor: 3.588

9.  The value of radiotherapy in breast cancer patients with isolated ipsilateral supraclavicular lymph node metastasis without distant metastases at diagnosis: a retrospective analysis of Chinese patients.

Authors:  San-Gang Wu; Jia-Yuan Sun; Juan Zhou; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Zhen-Yu He
Journal:  Onco Targets Ther       Date:  2014-02-15       Impact factor: 4.147

10.  Survey of UK practice for management of breast cancer metastases to the neck.

Authors:  B Bisase; C Kerawala
Journal:  Ann R Coll Surg Engl       Date:  2012-10       Impact factor: 1.891

View more
  1 in total

1.  Long-Term Outcomes of Breast Cancer Patients Who Underwent Selective Neck Dissection for Metachronous Isolated Supraclavicular Nodal Metastasis.

Authors:  Shin-Cheh Chen; Shih-Che Shen; Chi-Chang Yu; Ting-Shuo Huang; Yung-Feng Lo; Hsien-Kun Chang; Yung-Chang Lin; Wen-Ling Kuo; Hsiu-Pei Tsai; Hsu-Huan Chou; Li-Yu Lee; Yi-Ting Huang
Journal:  Cancers (Basel)       Date:  2021-12-29       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.